CDKN2A was found to be among the most recurrently differentially accessible and expressed T‐ALL‐specific regions and contributes most to the discrimination between leukemias and healthy T cells (PC1 loading = 0.000597; Appendix Fig S7 and Dataset EV11). Here, CDKN2A is linked to acute lymphoblastic leukemia.